Bank Julius Baer & Co. Ltd, Zurich Sarepta Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 May 16, 2024	BUY	$67.31 - $124.76 $11,442 - $21,209	170 New	170 $16,000
Q4 2023 Feb 02, 2024	SELL	$67.31 - $124.76 $55,328 - $102,552	-822 Reduced 82.86%	170 $16,000
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $5,330 - $6,426	-52 Reduced 4.98%	992 $120,000
Q2 2023 Jul 24, 2023	BUY	$106.4 - $157.19 $111,081 - $164,106	1,044 New	1,044 $120,000
Q1 2023 May 11, 2023	SELL	$117.53 - $155.99 $159,958 - $212,302	-1,361 Reduced 25.87%	3,899 $537,000
Q4 2022 Jan 24, 2023	SELL	$100.86 - $132.13 $171,058 - $224,092	-1,696 Reduced 24.38%	5,260 $682,000
Q3 2022 Nov 04, 2022	BUY	$75.71 - $119.24 $275,432 - $433,795	3,638 Added 109.64%	6,956 $769,000
Q2 2022 Jul 22, 2022	SELL	$62.69 - $88.44 $219,540 - $309,716	-3,502 Reduced 51.35%	3,318 $249,000
Q1 2022 May 09, 2022	SELL	$63.15 - $90.42 $266,303 - $381,301	-4,217 Reduced 38.21%	6,820 $533,000
Q4 2021 Feb 15, 2022	BUY	$77.28 - $99.42 $587,405 - $755,691	7,601 Added 221.22%	11,037 $994,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $4,156 - $5,826	-63 Reduced 1.8%	3,436 $318,000
Q2 2021 Jul 23, 2021	BUY	$69.38 - $86.75 $242,760 - $303,538	3,499 New	3,499 $272,000
Q1 2021 May 10, 2021	SELL	$72.25 - $168.95 $229,249 - $536,078	-3,173 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$125.56 - $178.74 $2,762 - $3,932	22 Added 0.7%	3,173 $541,000
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $66,672 - $94,910	531 Added 20.27%	3,151 $541,000
Q3 2020 Nov 10, 2020	BUY	$127.12 - $172.34 $91,526 - $124,084	720 Added 37.89%	2,620 $318,000
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $176,700 - $326,230	1,900 New	1,900 $272,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account